Role of nutrition in the formation of calcium-containing kidney stones

Nephron - Physiology

Volumn 98, Issue 2, 2004, Pages

  Taylor, Eric N ^a   Curhan, Gary C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Dietary risk factors; Kidney stones; Nephrolithiasis; Stone formers

Indexed keywords

ASCORBIC ACID; CALCIUM; CARBOHYDRATE; CITRIC ACID; MAGNESIUM; OMEGA 3 FATTY ACID; OXALIC ACID; PHOSPHORUS; PHYTATE; POTASSIUM; PROTEIN; PYRIDOXINE;

ALCOHOL CONSUMPTION; CALCIUM INTAKE; CALCIUM STONE; CARBONATED BEVERAGE; COFFEE; DIET THERAPY; DIETARY INTAKE; DISEASE ASSOCIATION; FAT INTAKE; GRAPEFRUIT JUICE; HUMAN; NEPHROLITHIASIS; NUTRITION; ORANGE JUICE; PATHOGENESIS; POTASSIUM INTAKE; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; URINALYSIS; URINARY EXCRETION; VITAMIN INTAKE;

ANIMALS; CALCIUM; HUMANS; KIDNEY CALCULI; NUTRITION PHYSIOLOGY;

EID: 7544235238     PISSN: 16602137     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080265     Document Type: Review

References (90)

1. Coe FL, Parks JH, Asplin JR: The pathogenesis and treatment of kidney stones. N Engl J Med 1992;327:1141-1152.
2. Levy FL, Adams-Huet B, Pak CY: Ambulatory evaluation of nephrolithiasis: An update of a 1980 protocol. Am J Med 1995;98:50-59.
3. Pak CY: Kidney stones. Lancet 1998;351:1797-1801.
4. Hess B: Nutritional aspects of stone disease. Endocrinol Metab Clins N Am 2002;31:1017-30.
5. Parivar F, Low RK, Stoller ML: The influence of diet on urinary stone disease. J Urol 1996;155:432-440.
6. Hsu TC, Chen J, Huang HS, Wang CJ: Association of changes in the pattern of urinary calculi in Taiwanese with diet habit change between 1956 and 1999. J Formos Med Assoc 2002;101:5-1010.
7. Hess B, Kok DJ: Nucleation, growth and aggregation of stone-forming crystals; in Coe FL, Favus MJ, Pak CY (eds): Kidney Stones: Medical and Surgical Management. Philadelphia, Lippincott-Raven Publishers, 1996, p 3.
8. Robertson WG, Peacock M, Hodgkinson A: Dietary changes and the incidence of urinary calculi in the UK between 1958 and 1976. J Chron Dis 1979;32:469-476.
9. Parks JH, Coward M, Coe FL: Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int 1997;51:894-900.
10. Robertson WG, Peacock M, Marshall RW, Marshall DH, Nordin BE: Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract. N Engl J Med 1976;294:249-252.
11. Wabner CL, Pak CY: Effect of orange juice consumption on urinary stone risk factors. J Urol 1993;149:1405-1408.
12. 3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med 1982;72:25-32.
13. Hess B: Low calcium diet in hypercalciuric calcium nephrolithiasis: First do no harm. Scan Microsc 1996;10:547-54; discussion 554-556.
14. Curhan GC, Willett WC, Rimm EB, Stampfer MJ: A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833-838.
15. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ: Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 1997;126:497-504.
16. Borghi L, Schianchi T, Meschi T, et al: Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002;346:77-84.
17. Zarembski PM, Hodgkinson A: Some factors influencing the urinary excretion of oxalic acid in man. Clin Chim Acta 1969;25:1-10.
18. Barilla DE, Notz C, Kennedy D, Pak CY: Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias: Effect of calcium and magnesium. Am J Med 1978;64:579-585.
19. Hess B, Jost C, Zipperle L, Takkinen R, Jaeger P: High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans. Nephrol Dial Transplant 1998;13:2241-2247.
20. Holmes RP, Goodman HO, Assimos DG: Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 2001;59:270-276.
21. Heller HJ, Doerner MF, Brinkley LJ, Adams-Huet B, Pak CY: Effect of dietary calcium on stone forming propensity. J Urol 2003;169:470-474.
22. Alpern RJ: Renal acidification mechanisms; in Brenner BM (ed): Brenner and Rector's The Kidney, ed 6. Philadelphia, Saunders, 2000, p 474.
23. Coe FL: Editorial: Something new about stones. J Urol 2003;169:478-479.
24. Curhan GC, Willett WC, Knight EL, Stampfer MJ: Dietary factors and the risk of incident kidney stones in younger women (Nurses' Health Study II). Arch Intern Med 2003, in press.
25. Robertson WG, Scurr DS, Bridge CM: Factors influencing crystallization of calcium oxalate in urine: A critique. J Crystal Growth 1981;53:182.
26. Curhan GC, Curhan SG: Diet and urinary stone disease. Curr Opin Urol 1997;7:222.
27. Brinkley LJ, Gregory J, Pak CY: A further study of oxalate bioavailability in foods. J Urol 1990;144:94-96.
28. Hagler L, Herman RH: Oxalate metabolism. I. Am J Clin Nutr 1973;26:758-765.
29. Menon M, Mahle CJ: Oxalate metabolism and renal calculi. J Urol 1982;127:148-151.
30. 2]oxalate. J Am Soc Nephrol 1999;10(suppl 14):S329-333.
31. Allison MJ, Cook HM, Milne DB, Gallagher S, Clayman RV: Oxalate degradation by gastrointestinal bacteria from humans. J Nutr 1986;116:455-460.
32. Baggio B, Gambaro G, Zambon S, et al: Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis. J Am Soc Nephrol 1996;7:613-620.
33. Baggio B, Priante G, Brunati AM, Clari G, Bordin L: Specific modulatory effect of arachidonic acid on human red blood cell oxalate transport: Clinical implications in calcium oxalate nephrolithiasis. J Am Soc Nephrol 1999;10(suppl 14):S381-84.
34. Whelan J, Surette ME, Hardardottir I, et al: Dietary arachidonate enhances tissue arachidonate levels and eicosanoid production in Syrian hamsters. J Nutr 1993;123:2174-2185.
35. Buck AC, Lote CJ, Sampson WF: The influence of renal prostaglandins on urinary calcium excretion in idiopathic urolithiasis. J Urol 1983;129:421-426.
36. Baggio B, Budakovic A, Nassuato MA, et al: Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. Kidney Int 2000;58:1278-1284.
37. Buck AC, Davies RL, Harrison T: The protective role of eicosapentaenoic acid [EPA] in the pathogenesis of nephrolithiasis. J Urol 1991;146:188-194.
38. Baggio B, Budakovic A, Priante G, Gambaro G, Manzato E, Khan S: Dietary fatty acid supplementation modulates the urinary excretion of calcium and oxalate in the rat. Insight into calcium lithogenesis. Nephron 2002;91:486-491.
39. Grases F, Garcia-Gonzalez R, Torres JJ, Llobera A: Effects of phytic acid on renal stone formation in rats. Scand J Urol Nephrol 1998;32:261-265.
40. Grases F, Costa-Bauza A: Phytate (IP6) is a powerful agent for preventing calcifications in biological fluids: Usefulness in renal lithiasis treatment. Anticancer Res 1999;19:3717-3722.
41. Grases F, Ramis M, Costa-Bauza A: Effects of phytate and pyrophosphate on brushite and hydroxyapatite crystallization: Comparison with the action of other polyphosphates. Urol Res 2000;28:136-140.
42. Grases F, Garcia-Ferragut L, Costa-Bauza A, March JG: Study of the effects of different substances on the early stages of papillary stone formation. Nephron 1996;73:561-568.
43. Grases F, March JG, Prieto RM, et al: Urinary phytate in calcium oxalate stone formers and healthy people - dietary effects on phytate excretion. Scand J Urol Nephrol 2000;34:162-164.
44. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A: Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: A 5-year randomized prospective study. J Urol 1996;155:839-843.
45. Parks JH, Goldfisher E, Asplin JR, Coe FL: A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol 2002;167:1607-1612.
46. Hess B: 'Bad dietary habits' and recurrent calcium oxalate nephrolithiasis. Nephrol Dial Transplant 1998;13:1033-1038.
47. Goodman HO, Holmes RP, Assimos DG: Genetic factors in calcium oxalate stone disease. J Urol 1995;153:301-307.
48. Friedman PA, Gesek FA: Calcium transport in renal epithelial cells. Am J Physiol 1993;264:F181-F198.
49. Muldowney FP, Freaney R, Moloney MF: Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int 1982;22:292-296.
50. Sakhaee K, Harvey JA, Padalino PK, Whitson P, Pak CY: The potential role of salt abuse on the risk for kidney stone formation. J Urol 1993;150:310-312.
51. Kok DJ, Iestra JA, Doorenbos CJ, Papapoulos SE: The effects of dietary excesses in animal protein and in sodium on the composition and the crystallization kinetics of calcium oxalate monohydrate in urines of healthy men. J Clin Endocrinol Metab 1990;71:861-867.
52. Breslau NA, Brinkley L, Hill KD, Pak CY: Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab 1988;66:140-146.
53. Lemann J Jr, Gray RW, Maierhofer WJ, Cheung HS: The importance of renal net acid excretion as a determinant of fasting urinary calcium excretion. Kidney Int 1986;29:743-746.
54. Hamm LL: Renal handling of citrate. Kidney Int 1990;38:728-735.
55. Hess B, Ackermann D, Essig M, Takkinen R, Jaeger P: Renal mass and serum calcitriol in male idiopathic calcium renal stone formers: Role of protein intake. J Clin Endocrinol Metab 1995;80:1916-1921.
56. Raskin P, Stevenson MR, Barilla DE, Pak CY: The hypercalciuria of diabetes mellitus: Its amelioration with insulin. Clin Endocrinol (Oxf) 1978;9:329-335.
57. Wood RJ, Allen LH: Evidence for insulin involvement in arginine- and glucose-induced hypercalciuria in the rat. J Nutr 1983;113:1561-1567.
58. Iguchi M, Umekawa T, Takamura C, et al: Glucose metabolism in renal stone patients. Urol Int 1993;51:185-190.
59. Coe FL, Parks JH: Idiopathic hypercalciuria: The contribution of Dr. Jacob Lemann, Jr. J Am Soc Nephrol 1994;5:S59-S69.
60. Kallner A: Serum bile acids in man during vitamin C supplementation and restriction. Acta Med Scand 1977;202:283-287.
61. Urivetzky M, Kessaris D, Smith AD: Ascorbic acid overdosing: A risk factor for calcium oxalate nephrolithiasis. J Urol 1992;147:1215-1218.
62. Kasidas GP: Assay of oxalate and glycolate in urine; in Rose GA (ed): Oxalate Metabolism in Relation to Urinary Stone. New York, Springer, 1988, pp 7-26.
63. 6, and the risk of kidney stones in men. J Urol 1996;155:1847-1851.
64. 6 and C and the risk of kidney stones in women. J Am Soc Nephrol 1999;10:840-845.
65. Wainer L, Resnick VA, Resnick MI: Nutritional aspects of stone disease; in Pak CY (ed): Renal Stone Disease: Pathogenesis, Prevention and Treatment. Boston, Martinus Nijhoff, 1987, pp 85-102.
66. Hess B, Zipperle L, Jaeger P: Citrate and calcium effects on Tamm-Horsfall glycoprotein as a modifier of calcium oxalate crystal aggregation. Am J Physiol 1993;265:F784-F791.
67. Erwin DT, Kok DJ, Alam J, et al: Calcium oxalate stone agglomeration reflects stone-forming activity: Citrate inhibition depends on macromolecules larger than 30 kilodaltons. Am J Kidney Dis 1994;24:893-900.
68. Levi M, McDonald LA, Preisig PA, Alpern RJ: Chronic K depletion stimulates rat renal brushborder membrane Na-citrate cotransporter. Am J Physiol 1991;261:F767-F773.
69. Sakhaee K, Alpern R, Poindexter J, Pak CY: Citraturic response to oral citric acid load. J Urol 1992;147:975-976.
70. Lemann J Jr, Pleuss JA, Gray RW, Hoffmann RG: Potassium administration reduces and potassium deprivation increases urinary calcium excretion in healthy adults [corrected]. Kidney Int 1991;39:973-983.
71. Pak CY, Koenig K, Khan R, Haynes S, Padalino P: Physicochemical action of potassium-magnesium citrate in nephrolithiasis. J Bone Miner Res 1992;7:281-285.
72. Reungjui S, Prasongwatana V, Premgamone A, Tosukhowong P, Jirakulsomchok S, Sriboonlue P: Magnesium status of patients with renal stones and its effect on urinary citrate excretion. BJU Int 2002;90:635-639.
73. Lindberg J, Harvey J, Pak CY: Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: Changes produced by food-magnesium interaction. J Urol 1990;143:248-251.
74. Liebman M, Costa G: Effects of calcium and magnesium on urinary oxalate excretion after oxalate loads. J Urol 2000;163:1565-1569.
75. Ettinger B, Citron JT, Livermore B, Dolman LI: Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 1988;139:679-684.
76. Khan SR, Shevock PN, Hackett RL: Magnesium oxide administration and prevention of calcium oxalate nephrolithiasis. J Urol 1993;149:412-416.
77. Rushton HG, Spector M: Effects of magnesium deficiency on intratubular calcium oxalate formation and crystalluria in hyperoxaluric rats. J Urol 1982;127:598-604.
78. Lau K, Wolf C, Nussbaum P, et al: Differing effects of acid versus neutral phosphate therapy of hypercalciuria. Kidney Int 1979;16:736-742.
79. Tizzani A, Casetta G, Piana P, Vercelli D: Wheat bran in the selective therapy of absorptive hypercalciuria: A study performed on 18 lithiasic patients. J Urol 1989;142:1018-1020.
80. Shah PJ, Green NA, Williams G: Unprocessed bran and its effect on urinary calcium excretion in idiopathic hypercalciuria. Br Med J 1980;281:426.
81. Ebisuno S, Morimoto S, Yasukawa S, Ohkawa T: Results of long-term rice bran treatment on stone recurrence in hypercalciuric patients. Br J Urol 1991;67:237-240.
82. 6 deficiency and oxalate nephrocalcinosis in the cat. Am J Med 1959;27:72.
83. Hannett B, Thomas DW, Chalmers AH, Rofe AM, Edwards JB, Edwards RG: Formation of oxalate in pyridoxine or thiamin deficient rats during intravenous xylitol infusions. J Nutr 1977;107:458-465.
84. Tiselius HG, Almgard LE: The diurnal urinary excretion of oxalate and the effect of pyridoxine and ascorbate on oxalate excretion. Eur Urol 1977;3:41-46.
85. Curhan GC, Willett WC, Speizer FE, Stampfer MJ: Beverage use and risk for kidney stones in women. Ann Intern Med 1998;128:534-540.
86. Shuster J, Finlayson B, Scheaffer RL, Sierakowski R, Zoltek J, Dzegede S: Primary liquid intake and urinary stone disease. J Chron Dis 1985;38:907-914.
87. Krieger JN, Kronmal RA, Coxon V, Wortley P, Thompson L, Sherrard DJ: Dietary and behavioral risk factors for urolithiasis: Potential implications for prevention. Am J Kidney Dis 1996;28:195-201.
88. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Stampfer MJ: Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 1996;143:240-247.
89. Hasling C, Sondergaard K, Charles P, Mosekilde L: Calcium metabolism in postmenopausal osteoporotic women is determined by dietary calcium and coffee intake. J Nutr 1992;122:1119-1126.
90. Shuster J, Jenkins A, Logan C, et al: Soft drink consumption and urinary stone recurrence: A randomized prevention trial. J Clin Epidemiol 1992;45:911-916.